Luye Pharma Group (LYPHF) Short Interest Ratio & Short Volume $0.37 0.00 (0.00%) (As of 07/5/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartShort InterestStock AnalysisChartShort Interest Luye Pharma Group Short Interest DataCurrent Short Interest18,511,300 sharesPrevious Short Interest24,779,800 sharesChange Vs. Previous Month-25.30%Dollar Volume Sold Short$6.85 millionShort Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2024Today's Trading Volume0 sharesAverage Trading Volume350 sharesToday's Volume Vs. Average0% Short Selling Luye Pharma Group ? Sign up to receive the latest short interest report for Luye Pharma Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYPHF Short Interest Over TimeLYPHF Days to Cover Over TimeLYPHF Percentage of Float Shorted Over Time Ad All American AssetsWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and global conflicts are escalating. Under Biden's disastrous policies, our savings are being devalued faster than ever. Protecting your wealth has never been more urgent. That's why we've created 3 Essential Guides to help you navigate these uncertain times and ensure your savings last as long as you do.Claim Your Kit Now Luye Pharma Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202418,511,300 shares $6.85 million -25.3%N/A0 $0.37 5/31/202424,779,800 shares $9.17 million -3.3%N/A0 $0.37 5/15/202425,635,300 shares $9.90 million -3.2%N/A256353 $0.39 4/30/202426,468,800 shares $10.22 million -0.4%N/A0 $0.39 4/15/202426,584,300 shares $10.27 million +0.7%N/A0 $0.39 3/31/202426,411,800 shares $10.20 million +0.7%N/A0 $0.39 Get the Latest News and Ratings for LYPHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Luye Pharma Group and its competitors with MarketBeat's FREE daily newsletter. 3/15/202426,230,300 shares $10.13 million No ChangeN/A0 $0.39 2/29/202426,230,300 shares $10.13 million +2.6%N/A0 $0.39 2/15/202425,563,300 shares $9.87 million +1.0%N/A0 $0.39 1/15/202424,896,000 shares $10.66 million +4.2%N/A0 $0.43 12/31/202323,888,200 shares $10.23 million +6.4%N/A0 $0.43 12/15/202322,443,200 shares $9.61 million +1.1%N/A0 $0.43 11/30/202322,192,200 shares $9.50 million +0.0%N/A0 $0.43 11/15/202322,183,200 shares $9.50 million +1.3%N/A0 $0.43 10/31/202321,893,200 shares $9.37 million +2.5%N/A0 $0.43 10/15/202321,355,700 shares $9.14 million +16.4%N/A0 $0.43 9/30/202318,347,500 shares $7.86 million +12.0%N/A0 $0.43 9/15/202316,376,000 shares $7.01 million +1.3%N/A0 $0.43 8/31/202316,159,500 shares $6.92 million +186.3%N/A0 $0.43 8/15/20235,644,000 shares $2.42 million -4.1%N/A56440 $0.43 7/31/20235,884,500 shares $2.77 million +8.0%N/A0 $0.47 7/15/20235,450,000 shares $2.56 million +6.6%N/A0 $0.47 6/30/20235,115,000 shares $2.40 million +3.9%N/A0 $0.47 6/15/20234,921,500 shares $2.31 million +29.1%N/A0 $0.47 5/31/20233,813,000 shares $1.79 million +223.6%N/A38130 $0.47 5/15/20231,178,500 shares $558,609.00 +162.5%N/A11785 $0.47 4/30/2023449,000 shares $336,750.00 -23.1%N/A0 $0.75 4/15/2023584,000 shares $438,000.00 -26.5%N/A0 $0.75 3/31/2023795,000 shares $0.00 +50.7%N/A0 $0.00 LYPHF Short Interest - Frequently Asked Questions What is Luye Pharma Group's current short interest? Short interest is the volume of Luye Pharma Group shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 18,511,300 shares of LYPHF short. Learn More on Luye Pharma Group's current short interest. Is Luye Pharma Group's short interest increasing or decreasing? Luye Pharma Group saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 18,511,300 shares, a decline of 25.3% from the previous total of 24,779,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short Luye Pharma Group stock? Short selling LYPHF is an investing strategy that aims to generate trading profit from Luye Pharma Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Luye Pharma Group? A short squeeze for Luye Pharma Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYPHF, which in turn drives the price of the stock up even further. How often is Luye Pharma Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYPHF, twice per month. The most recent reporting period available is June, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:LYPHF) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...All American Assets | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Luye Pharma Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Luye Pharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.